France: New HIV Prevention Injection (Apretude) Now Fully Covered
Long-Acting HIV Prevention Now Available in France: A New Era in Combating the Virus In a significant step forward in the fight against HIV, France has authorized the sale of cabotegravir, marketed as Apretude, a long-acting injectable medication for pre-exposure prophylaxis (PrEP). The decision, announced on February 26th, offers a new option for individuals at … Read more